Results 161 to 170 of about 5,607 (280)

A corpus-based analysis on the use of MAKE in sinologist Cyril Birch's English version of Mistress and Maid (Jiaohongji). [PDF]

PLoS One
Yu C, Wu Y.
europepmc   +1 more source

Design and Reliability Analysis of a Novel Redundancy Topology Architecture. [PDF]

Sensors (Basel), 2022
Li F, Liu W, Gao W, Liu Y, Hu Y.
europepmc   +1 more source

β‐TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1

Molecular Oncology, EarlyView.
Low levels of β‐TrCP (Panel A) allow the accumulation of BRCA1 and CtIP, which facilitate the repair of cisplatin‐induced DNA damage via homologous recombination (HR) and promote tumor cell survival. In contrast, high β‐TrCP expression (Panel B) leads to BRCA1 and CtIP degradation, impairing HR repair, resulting in persistent DNA damage and apoptosis ...
Rocío Jiménez‐Guerrero, Alejandro Belmonte‐Fernández, Mónica González‐Moreno, Laura Rodríguez‐Cordero, Begoña Pérez‐Valderrama, Joaquín Herrero‐Ruíz, Francisco Romero, Carmen Sáez, Miguel Á. Japón   +8 more
wiley   +1 more source

Reusing Stadiums for a Greener Future: The Circular Design Potential of Football Architecture. [PDF]

Front Sports Act Living, 2021
Wergeland ES, Hognestad HK.
europepmc   +1 more source

Nicotinamide N‐methyltransferase promotes drug resistance in lung cancer, as revealed by nascent proteomic profiling

Molecular Oncology, EarlyView.
AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou, Zhen Wang, Fei Yang, Xiao Han, Lei Li, Huadong Liu   +5 more
wiley   +1 more source

Theatre Reviews [PDF]

, 2012

core   +1 more source

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham, Jasibel Vasquez‐Gonzalez, Samantha M. Barnada, Salome Tchotorlishvili, Latese Jones, Ryan Maguire, Genevieve Lewis, Kinza Rizwan, Jenny Deng, Salma Koachar, Drithi Patel, Hailey Shankle, Tessa Mulders, Namra Ajmal, Charalambos Solomides, Emad S. Alnemri, Teresa F. Alnemri, Ayesha A. Shafi, Leonard G. Gomella, Wm Kevin Kelly, Steven B. McMahon, Matthew J. Schiewer   +21 more
wiley   +1 more source

Performance and Performativity [PDF]

, 2001
openaire   +3 more sources

Development of a generalised tool for evaluating success of clinical practice guidelines implementation (A-GIST). [PDF]

BMJ Evid Based Med
Zou K, Yang N, He S, Zeng L, Li H, Huang L, Yi Q, Gao X, Ren J, Zhang M, Wang Q, Zhang L.   +11 more
europepmc   +1 more source

The critical view of safety during laparoscopic cholecystectomy: Strasberg Yes or No? An Italian Multicentre study. [PDF]

Surg Endosc, 2021
Sgaramella LI, Gurrado A, Pasculli A, de Angelis N, Memeo R, Prete FP, Berti S, Ceccarelli G, Rigamonti M, Badessi FGA, Solari N, Milone M, Catena F, Scabini S, Vittore F, Perrone G, de Werra C, Cafiero F, Testini M, SYoN Italian Collaborative Group.   +19 more
europepmc   +1 more source